Opiate receptor mediated regulation of the immune response in vivo.
Weber
R J
RJ
Neuroimmunoendocrinology Unit, National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, Maryland 20892.
Ikejiri
B
B
Rice
K C
KC
Pert
A
A
Hagan
A A
AA
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D006241:Haptens / Q000276:immunology; D007111:Immunity, Cellular / Q000187:drug effects*; D007165:Immunosuppression Therapy; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D009020:Morphine / Q000494:pharmacology*; D009270:Naloxone / Q000494:pharmacology; D010047:Ovalbumin / Q000276:immunology; D011957:Receptors, Opioid / Q000502:physiology*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
D006241:Haptens; D011957:Receptors, Opioid; C038600:trinitrophenyl-ovalbumin; D009270:Naloxone; D009020:Morphine; D010047:Ovalbumin